Nitric oxide (NO) stimulates mitochondrial biogenesis. We recently reported that adiponectin synthesis is regulated by mitochondrial function in adipocytes. This study was undertaken to test the hypothesis that endothelial NO synthase (eNOS) plays an important role in adiponectin synthesis by producing NO and enhancing mitochondrial function in adipocytes. We examined the effects of eNOS knockdown on adiponectin synthesis in 3T3-L1 adipocytes and also examined plasma adiponectin levels and the mitochondria in adipose tissue of eNOS knockout (eNOS Ϫ/Ϫ ) mice with and without chronic administration of a NO donor. In cultured 3T3-L1 adipocytes, eNOS siRNA decreased rosiglitazone-induced adiponectin secretion, which was associated with decreases in mitochondrial proteins and biogenesis factors. Plasma adiponectin concentrations were reduced in adult eNOS Ϫ/Ϫ mice compared with age-matched wild-type mice. Mitochondrial contents in adipose tissue were reduced in eNOS Ϫ/Ϫ mice, and this was associated with decreased expression of mitochondrial biogenesis factors, increased levels of 8-hydroxyguanosine, a biomarker of oxidative stress, and morphological abnormalities in mitochondria. Rosiglitazone-induced increases in adiponectin expression and mitochondrial content were also reduced significantly in eNOS Ϫ/Ϫ mice. Chronic administration of a NO donor reversed mitochondrial abnormalities and increased adiponectin expression in adipose tissue of eNOS Ϫ/Ϫ mice. eNOS plays an important role in adiponectin synthesis in adipocytes by increasing mitochondrial biogenesis and enhancing mitochondrial function. endothelial nitric oxide synthase; mitochondrial biogenesis; oxidative stress; nitric oxide ADIPONECTIN, ONE OF THE ADIPOCYTE HORMONES, has many favorable effects on metabolism, including improvement of insulin action and reduction of atherosclerotic processes and cancer (1, 13, 17, 18, 36) . Unlike other adipocytokines, the plasma level of adiponectin is reduced in obese individuals due to selective suppression of its synthesis in adipocytes. We recently reported that mitochondrial function is essential for adiponectin synthesis in adipocytes, and mitochondrial dysfunction in adipose tissue explains decreased adiponectin synthesis in obesity (16). This study demonstrated that plasma adiponectin levels and adiponectin expression in adipose tissue were profoundly reduced in obese db/db mice, which was associated with decreased adipose tissue mitochondrial content and function. In addition, rosiglitazone, a peroxisome proliferator-activated receptor-␥ (PPAR␥) agonist, normalized plasma adiponectin levels and adiponectin expression in obese db/db mice by reversing the changes in mitochondrial content and function in adipose tissue.
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Nitric oxide (NO) has been shown to stimulate mitochondrial biogenesis (30, 31) , and evidence has accumulated that NO synthases play a crucial role in energy metabolism (14, 24) . Among the known NO synthases, endothelial NO synthase (eNOS) was identified originally as playing an important role in the regulation of vascular tone and blood pressure (9, 11, 38) . However, eNOS expression is not restricted to vascular endothelium and has been shown to be more ubiquitous (23, 39) . Interestingly, mice with homozygous inactivation of the eNOS gene (eNOS Ϫ/Ϫ mice) show features of the metabolic syndrome, including obesity, insulin resistance, hyperlipidemia, and hypertension (4, 9) . Although the underlying mechanisms of these metabolic derangements have not been clearly elucidated, recent studies have suggested that eNOS plays an important role in mitochondrial biogenesis (30, 42) ; eNOS Ϫ/Ϫ mice showed mitochondrial dysfunction and significant intramyocellular lipid accumulation in skeletal muscle (20) . Insulin resistance in eNOS Ϫ/Ϫ mice may arise from impaired mitochondrial oxidation of fatty acid and the resulting intracellular accumulation of fat moieties, such as long-chain acylCoA esters, diacylglycerol, and ceramide, that interfere with insulin signaling (6, 26, 28) .
On the basis of the evidence for the important roles of mitochondrial function in adiponectin synthesis and eNOS in mitochondrial biogenesis, we propose the hypothesis that eNOS plays a major role in adiponectin synthesis in adipocytes. To test this hypothesis, we examined whether adiponectin synthesis is affected by eNOS inactivation in cultured 3T3-L1 adipocytes and whether adiponectin expression in adipocytes and plasma adiponectin concentrations are decreased in eNOS Ϫ/Ϫ mice.
MATERIALS AND METHODS
Cell culture. 3T3-L1 preadipocytes were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum in an incubator with 5% CO 2-95% O2 at 37°C. 3T3-L1 preadipocytes were differentiated to mature adipocytes by a conventional method (44) and were maintained as subconfluent cultures.
Animals. The C57BL/6J mice and the eNOS Ϫ/Ϫ colony founders (B6.129P2-Nos3 tm1Unc ) were purchased from the Jackson Laboratory. Male knockout (eNOS Ϫ/Ϫ ) and wild-type (eNOS ϩ/ϩ ) mice were generated by mating heterozygous (eNOS ϩ/Ϫ ) mice. All mice were housed at ambient temperature (22 Ϯ 1°C) with 12:12-h light-dark cycles and free access to water and mouse chow. All animal experiments were approved by the Institutional Animal Care and Use Committees of the Asan Institute for Life Sciences.
Genotyping. All eNOS
Ϫ/Ϫ mice were confirmed for having knockout mutants by polymerase chain reaction (PCR). DNA samples were amplified by one sense primer (5-CTCCAACTTAGTGCAGGTCT-3 for binding to eNOS DNA) and two antisense primers (5-ATGGTT-GCCTTCACACGCTT-3 for normal sequence and 5-CTTCCTCGT-GCTTTACGGTA-3 for knockout targeting sequence) (Supplemental Fig. S1 ; Supplemental Material for this article is available at the AJP-Endocrinology and Metabolism web site) (8) .
Experimental procedures. Wild-type and eNOS Ϫ/Ϫ mice were weaned at 4 wk of age and maintained on normal mouse chow. At several time points, blood samples were obtained from retroorbital sinus. In a separate set of experiments, animals at 8 (adolescent group) and 30 wk of age (adult group) were euthanized to obtain their epididymal adipose tissues, which were then kept frozen at Ϫ80°C. To explore the effects of NO on adiponectin synthesis, eNOS Ϫ/Ϫ mice were treated for 20 wk, starting at 10 wk of age, with the NO donor 3-morpholinosydnonimine (SIN-1; 20 mg·kg ; Sigma-Aldrich, St. Louis, MO), which was added to drinking water. In another experiment, we examined the effect of rosiglitazone; eNOS Ϫ/Ϫ and wild-type mice were treated for 4 wk, starting at 18 wk of age, with rosiglitazone (20 mg·kg Ϫ1 ·day Ϫ1 ; GlaxoSmithKline, Middlesex, UK), which was added to powdered standard mouse chow (7) .
Measurement of adipocytokines. Adiponectin concentrations in culture medium and mouse plasma were measured by radioimmunoassay (Linco Research, St. Charles, MO). The levels of plasma leptin, TNF␣, and resistin were determined using enzyme-linked immunosorbent assay kits from R & D systems (Minneapolis, MN) according to the manufacturer's instructions.
Western blot analysis. 3T3-L1 cells and adipose tissues of mice were lysed in a buffer containing 20 mM Tris·HCl (pH 7.4), 1 mM EDTA, 140 mM NaCl, 1% NP-40, 1 mM Na 3VO4, 1 mM phenylmethylsulfonyl fluoride, 50 mM NaF, and 10 g/ml aprotinin. Proteins (40 -50 g) were subjected to immunoblotting with specific antibodies. Band intensities were quantified by a densitometer. The results were normalized to ␤-actin to correct for variations in sample loading and are expressed as percentages of control signals (%control) in each blot to correct for variations between blots. Anti-cytochrome c and anti-cytochrome c oxidase subunit II antibodies were from Cell Signaling Technology (Danvers, MA). Anti-mitochondrial transcription factor A (mtTFA) and anti-nuclear respiratory factor-1 (NRF-1) antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-hydroxynonenal (HNE) antibody was from R & D Systems. AntieNOS antibody was from Calbiochem (La Jolla, CA). Anti-␤-actin antibody was from Sigma (St. Louis, MO).
Analysis of high-molecular-weight adiponectin. Plasma samples (1 l) were diluted by a nonreducing sample buffer and subjected to 6% SDS-PAGE under nonreducing and non-heat-denaturing conditions (19, 34, 43) . The samples were then blotted onto nitrocellulose membranes and immunostained with anti-mouse adiponectin antibody (Adipogen, Seoul, Republic of Korea).
Quantification of mitochondrial DNA content. Mitochondrial DNA (mtDNA) contents were quantified by real-time PCR on an ABI PRISM 7000 sequence detection system (Applied Biosystems, Foster City, CA) using a SYBR Green kit (Applied Biosystems) according to the manufacturer's protocol. Mouse nuclear 18S rRNA was used as the internal control. The ratio of the target gene to 18S rRNA expression level was calculated by subtracting the threshold cycle (C T) of the target gene from the CT of 18S rRNA and raising 2 to the power of this difference. The primers for detecting the cytochrome b gene (14,146 -15,289 ) of murine mitochondrial genome were designed on the basis of the GenBank nucleotide sequences. The primer sequences were forward primer 5=-CCA CTT CAT CTT ACC ATT TA-3= and reverse primer 5=-ATC TGC ATC TGA GTT TAA TC-3= (GenBank AB042432.1; Mus musculus domesticus mitochondrion) (2) .
Quantification of PPAR␥ coactivator-1␣ mRNA levels. PPAR␥ coactivator-1␣ (PGC-1␣) mRNA levels were quantified by real-time PCR. The gene-specific primers for the measurement of PGC-1␣ mRNA were forward primer 5=-AGCCGTGACCACTGACAACG-3= and reverse primer 5=-GCTGCATGGTTCTGAGTGCT-3= (NM 008904). The primers for the measurement of mouse 18S rRNA, the control gene, were forward primer 5=-GGGAGCCTGAGAAACGGC-3= and reverse primer 5=-GGGTCGGGAGTGGGTAATTT-3= (NR 003278).
Small interfering RNA. The murine eNOS small interfering RNA (siRNA; M-040956-00-0010) and a nontargeting control siRNA (D-001210-01-100) were purchased from Dharmacon (Lafayette, CO) (Supplemental Fig. S2 ), and 2 ϫ 10 5 cells were seeded onto six-well plates and transfected with 100 pmol of siRNA using DharmaFECT (Dharmacon) according to the manufacturer's instructions.
Immunofluorescence. Paraffin sections of adipose tissues were deparaffinized in xylene, rehydrated through graded ethanol, and washed in H 2O. All of the sections were incubated in citrate buffer (pH 6) and heated in a microwave for 15 min for antigen unmasking, and then the slides were cooled to room temperature, permeabilized in 0.5% Triton X-100 in PBS for 5 min, and blocked with 1% normal horse serum. For 8-hydroxyguanosine (8-OHG) immunostaining, anti-8-OHG goat polyclonal antibody (Santa Cruz Biotechnology) was used. FITC-conjugated anti-goat secondary antibody (Zymed, Carlsbad, CA) was used after primary antibody incubation. Nuclei were counterstained with 4=6-diamidino-2-phenylindole (Invitrogen, Carlsbad, CA), and fluorescence images were captured using confocal laser scanning microscope (LSM510; Zeiss, Thornwood, NY).
Electron microscopy. Epididymal adipose tissues were washed in fresh 0.1 M phosphate buffer (pH 7.4) and fixed in 1% glutaraldehyde-4% paraformaldehyde in the same buffer for 4 h at 4°C. Tissues were then washed three times in 0.1 M fresh phosphate buffer (pH 7.4) for 10 min. Tissues were fixed in 1% OsO 4 for 1 h at room temperature and washed three times in 0.1 M phosphate buffer for 10 min each time. Embedding in Epon was performed according to standard techniques after dehydration of the tissues with ethyl alcohol and propylene oxide. Ultrathin sections (60 nm) were cut from the blocks using a Reichart-Jung ultratome E with a diamond knife. The sections were collected and stained with uranyl acetate followed by lead citrate and then observed using a transmission electron microscope (Hitachi H-7100; Hitachi, Nackashi, Japan).
Statistics. All values are given as means Ϯ SE. Differences between two groups were assessed using unpaired two-tailed t-test. Data from more than two groups were assessed by analysis of variance followed by a post hoc least significant difference test. Statistical analyses were performed using SPSS-PC13.
RESULTS
eNOS inactivation decreases adiponectin secretion in cultured adipocytes. We reported previously that rosiglitazone increases adiponectin synthesis in adipocytes by increasing mitochondrial biogenesis (16) . In this study, we examined the effects of eNOS knockdown via eNOS siRNA on rosiglitazone-induced adiponectin synthesis in cultured 3T3-L1 adipocytes. As expected (16, 25) , rosiglitazone increased adiponectin seceretion, which was accompanied by increases in mtDNA and protein contents and the expressions of PGC-1␣ and mtTFA in the cells (Fig. 1, A-D) . These effects of rosiglitazone were decreased significantly in cells treated with eNOS siRNA (Fig. 1, A-D) . These in vitro data suggest that eNOS is critically required for mitochondrial biogenesis and adiponectin secretion in cultured adipocytes.
Plasma adiponectin level is decreased in adult eNOS
Ϫ/Ϫ mice. We next examined whether the plasma concentration of adiponectin is decreased in eNOS Ϫ/Ϫ mice. Contrary to our expectation, plasma adiponectin levels were not different between eNOS Ϫ/Ϫ and wild-type mice at adolescent ages (e.g., 8 or 11 wk; Fig. 2A ). Plasma adiponectin concentrations increased with age in both eNOS Ϫ/Ϫ and control mice until 22 wk of age, but in eNOS Ϫ/Ϫ mice they decreased significantly from 25 wk of age compared with wild-type mice at the same ages ( Fig. 2A) . Adiponectin expression in adipose tissue was also significantly decreased in eNOS Ϫ/Ϫ mice at 30 wk of age (Fig. 2B) . Adiponectin circulates in the bloodstream as several oligomeric complexes, including trimers, hexamers, and highmolecular-weight (HMW) oligomeric complexes. Plasma levels of HMW oligomers, which are functionally most active (32), were also reduced in 30-wk-old eNOS Ϫ/Ϫ mice compared with age-matched wild-type mice (Fig. 2C) . On the other hand, plasma levels of other adipocytokines, such as leptin, TNF␣, and resistin, were not different between wild-type and eNOS Ϫ/Ϫ mice at 30 wk of age (Supplemental Fig. S3 ). We next examined whether chronic NO deficiency in eNOS Ϫ/Ϫ mice was responsible for the decrease in plasma adiponectin level. Chronic administration of SIN-1, a NO donor, to eNOS Ϫ/Ϫ mice increased both plasma adiponectin (total and HMW) and adiponectin expression in adipose tissue to levels similar to those in wild-type mice (Fig. 2, C-E) .
Mitochondrial content is decreased in adult eNOS Ϫ/Ϫ mice. We next sought possible explanation for age-dependent decreases in plasma adiponectin level in eNOS Ϫ/Ϫ mice. There were no differences in mitochondrial DNA content (Fig. 3A) and protein expression (Fig. 3B ) between wild-type and eNOS Ϫ/Ϫ mice at 8 wk of age. However, these measurements became significantly lower in eNOS Ϫ/Ϫ mice than in wild-type mice at 30 wk of age (Fig. 3, A and B) . Interestingly, the expressions of mitochondrial biogenesis factors, i.e., PGC-1␣ (Fig. 3C) , NRF-1, and mtTFA (Fig. 3B) , were significantly higher at 30 compared with 8 wk of age in wild-type mice. In contrast, these expressions were significantly lower in 30-wkold eNOS Ϫ/Ϫ mice compared with 8-wk-old eNOS Ϫ/Ϫ mice or age-matched wild-type mice (Fig. 3, A-C) .
The expression of HNE, a marker of lipid peroxidation, in adipose tissue increased with age in both wild-type and eNOS Ϫ/Ϫ mice, and there was no significant difference between eNOS Ϫ/Ϫ and wild-type mice (Fig. 3D) . On the other hand, immunohistological examinations disclosed that the expression of 8-OHG, a marker of oxidatively damaged DNA, was increased significantly in adipocytes of 30-wk-old eNOS Ϫ/Ϫ mice but not in 30-wk-old control mice (Fig. 4) or in 8-wk-old eNOS Ϫ/Ϫ mice (data not shown). 8-OHG staining was observed both in cytosolic area as well as in the nucleus.
Mitochondrial changes in eNOS Ϫ/Ϫ mice are reversed by SIN-1 administration. Chronic administration of SIN-1 fully reversed the decreases in mtDNA content and the expressions of mitochondrial proteins and biogenesis factors observed in eNOS Ϫ/Ϫ mice (Fig. 5 ). In addition, SIN-1 administration reversed 8-OHG staining (data not shown). Electron microscopy revealed disarrangement and interruption of the cristae in the mitochondria of 30-wk-old eNOS Ϫ/Ϫ mice (Fig. 6 ). In addition, the number of mitochondria was significantly reduced in 30-wkold eNOS Ϫ/Ϫ mice compared with age-matched wild-type mice. These changes in the mitochondria were nearly completely prevented by SIN-1 treatment. These results indicate that a lack of NO is responsible for decreased adiponectin synthesis, decreased mitochondrial biogenesis, and oxidative mitochondrial damage in adult eNOS Ϫ/Ϫ mice.
Rosiglitazone stimulation of adiponectin synthesis is impaired in eNOS
Ϫ/Ϫ mice. We next examined whether rosiglitazone stimulation of adiponectin synthesis is mediated by eNOS in vivo. For this purpose, we compared the effects of rosiglitazone administration in wild-type and eNOS Ϫ/Ϫ mice. Rosiglitazone was administered for 4 wk starting at 18 wk of age. Plasma adiponectin levels and adiponectin expression in adipose tissue were increased significantly by the rosiglitazone treatment in wild-type mice (Fig. 7, A and B) . There were also significant increases in mtDNA content and the expression of mitochondrial proteins and biogenesis factors (Fig. 7, C and  D) . These effects of rosiglitazone treatment were all reduced significantly in eNOS Ϫ/Ϫ mice (Fig. 7, A-D) . These results suggest that rosiglitazone-induced changes in adiponectin synthesis and mitochondrial content are, at least in part, mediated by eNOS-dependent mitochondrial biogenesis.
DISCUSSION
NO produced by eNOS is involved in many different components of the metabolic regulation. NO production in the endothelium is stimulated by insulin to increase blood flow (47) . The NO-dependent increase in blood flow is an important mediator of insulin-stimulated glucose disposal in insulin target tissues (e.g., skeletal muscle) (15) , and impairment of insulin's action on NO production is a cardinal manifestation of vascular insulin resistance in the metabolic syndrome (12, 29) . In the present study, we provide evidence that eNOS in adipose tissue is involved in the production of adiponectin, one of the most important hormones produced by adipocytes. We reported previously that mitochondrial function is linked to adiponectin synthesis in adipocytes (16) . Adipocytes undergo maturation by two steps, differentiation and hypertrophy (46) . During the early stage of maturation (differentiation), adipocytes have high levels of metabolic activities and increased fuel consumption. These young cells are relatively small and sensitive to insulin and show increased adiponectin expression. Increased mitochondrial function may be required for adipocyte differentiation since it requires much energy. In addition, it may be required for efficient adiponectin synthesis, since adipocytes produce huge quantities of adiponectin compared with other proteins (5); adiponectin synthesis could be a major energy-consuming process in adipocytes. Newly differentiated cells with increased mitochondrial content would be small in size because increased fatty acid oxidation would reduce intracellular triglyceride accumulation. By contrast, older cells lose most of their metabolic activities, increase in size (hypertrophy), and decrease adiponectin synthesis. Impaired mitochondrial function in hypertrophic adipose cells may explain decreases in adiponectin synthesis and lower plasma adiponectin levels in obesity (16) . In the present study, we extended this concept and showed that proper function of eNOS in adipocytes is necessary for mitochondrial biogenesis and adiponectin synthesis.
In cultured adipocytes, inactivation of eNOS decreased rosiglitazone-induced adiponectin secretion. In addition, plasma adiponectin concentrations and adiponectin expression in adipose tissue were reduced significantly in adult eNOS Ϫ/Ϫ mice compared with age-matched wild-type mice. These decreases in adiponectin synthesis were accompanied by decreased adipocyte contents of mitochondrial DNA, mitochondrial proteins, and mitochondrial biogenesis factors both in vitro and in vivo. We also found that oxidative mitochondrial damage was increased in adipose tissue of 30-wk-old eNOS Ϫ/Ϫ mice. All of these changes in the mitochondria and adiponectin synthesis in adipocytes of eNOS Ϫ/Ϫ mice were reversed by chronic administration of SIN-1, an NO donor. It should be noted that SIN-1 produces superoxide as well as NO (27) and may not be an ideal NO donor. Beneficial effect of SIN-1 in vivo may be due to high levels of superoxide dismutase in animal tissues.
Compared with age-matched control mice, plasma adiponectin levels were lower in adult (e.g., Ͼ25 wk of age) eNOS Ϫ/Ϫ mice but not in younger eNOS Ϫ/Ϫ mice. Similiarly, the expressions of PGC-1␣, NRF-1, and mtTFA were decreased in 30-wk-old eNOS Ϫ/Ϫ mice but not in 8-wk-old (adolescent) eNOS Ϫ/Ϫ mice. It is not clear why mitochondrial biogenesis is not changed in adolescent eNOS Ϫ/Ϫ mice. The mitochondrial content in the cell is determined by the balance between mitochondrial biogenesis and degradation (or damage). The mitochondria are one of the major sources of reactive oxygen species (ROS) production in the cell (35) . On the other hand, because the mitochondria are devoid of histone, they are susceptible to damage by ROS (45) . Oxidative stress is responsible for aging-dependent mitochondrial dysfunction (22) . A recent study also showed that oxidative stress in skeletal muscle is responsible for mitochondrial dysfunction in diet-induced insulin-resistant mice (3) . Evidence suggests that mitochondrial biogenesis is a key regulator of mitochondrial ROS production (10, 33, 41) ; increased mitochondrial contents help to reduce ROS production. With regard to this, nonlethal concentrations of ROS stimulate mitochondrial biogenesis (21, 37), providing a defensive mechanism against increased oxidative stress. In the present study, the expression of HNE in adipose tissue was increased significantly in adult vs. adolescent mice in both wild-type and eNOS Ϫ/Ϫ mice. This was associated with increases in the expressions of mitochondrial biogenesis markers in adult wild-type mice. Thus, it can be speculated that increased mitochondrial biogenesis in adipocytes of adult wild-type mice was a compensatory defensive mechanism that protects cells from mitochondrial damage. On the other hand, a failure to increase mitochondrial biogenesis in adipocytes of adult eNOS Ϫ/Ϫ mice could have resulted in mitochondrial damage, reducing mitochondrial function and adiponectin synthesis. We found that 8-OHG expression, a marker of oxidatively damaged DNA (40), was found specifically in adult eNOS Ϫ/Ϫ mice. Interestingly, 8-OHG staining was observed both in the cytosol and in the nucleus, suggesting its presence in mitochondria. Taken together, these results suggest that there is a certain threshold of mitochondrial content or function that is required for the maintainence of adiponectin synthesis in adipocytes. Increased oxidative stress in adipose tissue, when not overcome by adequate mitochondrial biogenesis, may result in decreased mitochondrial content, abnormalities in mitochondrial structure, and decreased adiponectin synthesis as seen in adult eNOS Ϫ/Ϫ mice. In conclusion, we demonstrated that plasma adiponectin levels and adiponectin expression in adipose tissue were decreased in adult eNOS Ϫ/Ϫ mice. These changes were associated with decreased mitochondrial biogenesis and increased oxidative stress in adipocytes. Thus, the present data indicate that eNOS plays an important role in mitochondrial function and adiponectin synthesis in adipocytes.
